Comparing Imaginal Exposure and Imagery Rescripting in Treatment of Posttraumatic Stress Disorder (PTSD)

NCT ID: NCT00891098

Last Updated: 2013-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The outcome of trauma treatment (Posttraumatic Stress Disorder - PTSD) may be influenced by which emotions that are predominant among current symptoms, e.g. fear, anger, guilt, shame. Different treatment procedures for processing traumatic memories may resolve different emotions. This study compares two different treatment procedures of working with trauma memories in PTSD treatment (namely, Imaginal Exposure and Imagery Rescripting) in order to test this.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objectives of this study are:

1. To assess the relative efficacy of the two procedures in inpatient treatment for PTSD
2. To assess whether the predominant emotions in the traumatic memories moderate the outcome of the different procedures
3. To assess whether theory-derived constructs mediate outcome and whether the mediating relationships are different in the two treatments
4. To provide a theoretical account of the two models
5. To psychometrically evaluate 3 new measures

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Imaginal exposure

Group Type ACTIVE_COMPARATOR

Imaginal exposure

Intervention Type BEHAVIORAL

7 individual sessions of imaginal exposure of trauma memories according to the prolonged exposure treatment manual

Imagery rescripting

Group Type EXPERIMENTAL

Imagery rescripting

Intervention Type BEHAVIORAL

7 individual sessions of imagery rescripting of trauma memories according to the imagery rescripting and reprocessing therapy manual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Imaginal exposure

7 individual sessions of imaginal exposure of trauma memories according to the prolonged exposure treatment manual

Intervention Type BEHAVIORAL

Imagery rescripting

7 individual sessions of imagery rescripting of trauma memories according to the imagery rescripting and reprocessing therapy manual

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

prolonged exposure pe rescripting irrt

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DSM-IV diagnosis of PTSD identified as primary diagnosis
* Accepts withdrawal of all psychotropic medication

Exclusion Criteria

* Extensive dissociative symptoms or current psychosis,
* Current suicidal risk,
* Extensive current substance or alcohol abuse, or
* Ongoing trauma
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oslo

OTHER

Sponsor Role collaborator

Modum Bad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asle Hoffart

phd

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Asle Hoffart, PhD

Role: STUDY_CHAIR

Modum Bad and University of Oslo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Modum Bad

Vikersund, Buskerud, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2-Hoffart

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.